Skip to main content
. 2021 Nov 24;36(5):391–404. doi: 10.1007/s10822-021-00421-6

Fig. 10.

Fig. 10

Case study on ligand selectivity with dopamine D2 and D3 receptors. a Representative pharmacophore models for D2R and D3R. b, c Representative substructures obtained for D2R and D3R via saliency analysis, sorted by pharmacophore identity. d Representative molecules showing saliency prediction differences with respect to the dopamine receptor types